Aurora B: a new prognostic marker and therapeutic target in cancer

Curr Med Chem. 2011;18(4):482-96. doi: 10.2174/092986711794480203.

Abstract

Aurora B is a serine-threonine kinase belonging to the highly conserved Aurora family of mitotic kinases. Aurora B is a chromosomal passenger protein involved in chromosome segregation, spindle-checkpoint, and cytokinesis. Alteration of each of these steps could induce aneuploidy, one of main features, and driving force of cancer progression. The overexpression of Aurora B has been observed in several tumor types, and has been linked with a poor prognosis of cancer patients. In this review we will focus on the role of Aurora B in cancer development, its role as a prognostic marker, and the clinical outcome of recently developed Aurora(s) inhibitors.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aurora Kinase B
  • Aurora Kinases
  • Biomarkers, Tumor / metabolism
  • Chromosome Segregation
  • Cytokinesis
  • Humans
  • Mitosis
  • Neoplasms / drug therapy*
  • Neoplasms / etiology
  • Prognosis
  • Protein Kinase Inhibitors / chemistry
  • Protein Kinase Inhibitors / therapeutic use
  • Protein Serine-Threonine Kinases / antagonists & inhibitors*
  • Protein Serine-Threonine Kinases / metabolism
  • Protein Serine-Threonine Kinases / physiology*

Substances

  • Biomarkers, Tumor
  • Protein Kinase Inhibitors
  • AURKB protein, human
  • Aurora Kinase B
  • Aurora Kinases
  • Protein Serine-Threonine Kinases